Novartis Defends Exelon Patents At Fed. Circ.
Novartis Pharmaceuticals Corp. told the Federal Circuit Monday that two patents covering its Exelon patch were variously both valid and had been infringed, in appeals stemming from mixed rulings in disputes...To view the full article, register now.
Already a subscriber? Click here to view full article